Wednesday, June 29, 2022
wellness India Expo

Ahammune Biosciences partners Veeda Clinical Research for first human studies of...

63
First-in-human (Phase 1) studies of Ahammune’s investigational new drug for vitiligo- AB1001 that targets pathways involved in triggering autoimmunity in skin are currently being conducted by Veeda Clinical Research at Ahmedabad, Gujarat

NHA to host Hackathon Series under Ayushman Bharat Digital Mission

21
Slated to be held from 14th to 17th July 2022, the hackathon is being organized with the aim to build innovative solutions for healthcare service delivery using UHI. Winners stand to win exciting cash prizes

MOST READ ARTICLES

Face to Face

FACE to FACE: Abhishek Mohan, Founder & CEO, HempStreet

57
Click to watch the full interview Abhishek Mohan, Founder and Chief Executive Officer, HempStreet has been in the startup space for over 15 years now....

Chat with BioVoice

“India’s medtech industry has the potential to serve global market”

351
In an exclusive interaction, Krista Donaldson, Chief Executive Officer, Equalize Health shares her views on the medical devices market, company's current activities, India plans, future outlook and much more

R&D

Events